Raul C. Braylan

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

Neha Korde, Mark Roschewski, Adriana Zingone et al. · JAMA Oncology · 2015 · 308 citations · Full text

Non-Endemic Burkitt's Lymphoma

Risa B. Mann, Elaine S. Jaffe, Raul C. Braylan et al. · New England Journal of Medicine · 1976 · 254 citations

Immunology, Pathology, Immunophenotyping +16

Disruption of <i>in vivo</i> Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study

Carsten Utoft Niemann, Sarah E. M. Herman, Irina Marić et al. · Clinical Cancer Research · 2015 · 191 citations · Full text

Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia

Nidal M. Almasri, Ricardo E. Duque, Jose Iturraspe et al. · American Journal of Hematology · 1992 · 176 citations

Chronic Lymphocytic Leukemia, Intense Cd20 Expression, Immunology +18

GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia

Karthik A. Ganapathi, Danielle M. Townsley, Amy P. Hsu et al. · Blood · 2014 · 159 citations · Full text